Monthly Archives: October 2026


A Female Life Stage Framework for Cardiovascular Health Across the Lifespan

A new multisociety scientific statement introduces the Female Life Stage framework to improve cardiovascular disease prevention and management in girls and women by integrating hormonal, psychosocial, and cardiovascular health across the lifespan. These interconnected domains often experience concurrent dysregulation, which is associated with increased cardiovascular risk, yet care remains fragmented […]


Low Protein Intake Linked to Higher Risks of Kidney Failure and Death in CKD

A prospective cohort study of 1,861 patients with nondialysis-dependent chronic kidney disease (CKD) in South Korea found that very low protein intake was associated with higher risks of kidney failure requiring replacement therapy (KFRT) and all-cause mortality, without a significant association with major adverse cardiovascular events. Over a median follow-up […]


SGLT2 Inhibitors Modestly Increase Hemoglobin and Hematocrit

A meta-analysis of 85 randomized clinical trials involving 70,543 participants found that sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with small but statistically significant increases in hemoglobin and hematocrit levels compared with control treatments, although the clinical significance of these changes remains unclear. The trials had a median follow-up of […]


Circadian Depression Subtype Linked to More Severe Symptoms and Poorer Antidepressant Response

A circadian subtype of depression is associated with earlier disease onset, more severe clinical features, poorer response to commonly prescribed antidepressants, and a distinct genetic risk profile. In a nationwide Australian Genetics of Depression Study, 2,604 participants (23%) met criteria for this subtype, defined by at least three circadian-associated features, […]


A Common CD36 Variant of Dilated Cardiomyopathy in Individuals of African Ancestry

A multicohort genetic association study found that the ancestry-enriched CD36 Y325* variant accounted for a greater population-level burden of dilated cardiomyopathy (DCM) among individuals of predominantly African ancestry than truncating variants in TTN, the most common established monogenic cause of DCM. Across four US cohorts involving 82,623 individuals of predominantly […]